Coronavirus (COVID-19) Current Therapy Market

Global Coronavirus (COVID-19) Current Therapy Market Size, Forecasts, And Opportunities

Learn about the global coronavirus (COVID-19) current therapy market through The Business Research Company, which provides information on coronavirus (COVID-19) current therapy market size, coronavirus (COVID-19) current therapy market drivers and restraints, coronavirus (COVID-19) current therapy market players, the COVID-19 impact on the coronavirus (COVID-19) current therapy market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global coronavirus (COVID-19) current therapy market is expected to grow from $14.63 billion in 2020 to $16.8 billion in 2021 at a compound annual growth rate (CAGR) of 14.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The COVID-19 current therapy market is expected to reach $35.42 billion in 2025 at a CAGR of 20%.

The outbreak of the pandemic COVID-19 is expected to drive innovation in coronavirus (COVID-19) current therapy, thus driving the market during the forecast period.

Request A Sample For The Global Coronavirus (COVID-19) Current Therapy Market Report:

The coronavirus (COVID-19) current therapy market consists of sales of drugs currently used for the treatment of COVID-19 infection. The market report includes single-drug therapeutics and combination drug therapeutics used in treating COVID-19 patients. The market consists of revenue generated by the companies that manufacture coronavirus current therapeutics by the sales of these products.

Global coronavirus (COVID-19) current therapy market segments include:

By Drug Type: Remdesivir, Hydroxychloroquine, Ritonavir, Lopinavir, Interferon Beta, Others

By End User: Hospitals, Clinics, Research Institutes, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Convalescent Plasma Therapy is used as an experimental therapy to treat COVID-19 patients. The blood plasma of patients who have recovered from a disease is called convalescent plasma (CP). Convalescent Plasma (CP) therapy is a type of passive antibody therapy in which blood plasma is isolated from patients who have recovered from the disease of interest and administered to the patient with severe disease to suppress the virulence and improve clinical symptoms. The blood plasma of recovered COVID-19 patients has antibodies to fight COVID-19 infection.

TBRC’s coronavirus (COVID-19) current therapy market report covers:

Major Market Players: Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Altimmune, Clover Biopharmaceuticals, Inovio Pharmaceuticals, Inc., Biocryst Pharma, Gilead Sciences, and Regeneron Pharmaceuticals.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Coronavirus (COVID-19) Current Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides coronavirus (COVID-19) current therapy market overviews, analyzes and forecasts market size, share, coronavirus (COVID-19) current therapy market players, coronavirus (COVID-19) current therapy market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s coronavirus (COVID-19) current therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

COVID-19 Detection Test Kits And Consumables Global Market Report 2021

COVID-19 Drug Associated APIs Global Market Report: COVID-19 Growth And Change

COVID-19 Rapid Test Kits Global Market Report 2021: COVID-19 Implications And Growth

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293


Follow us on LinkedIn:

Follow us on Twitter:

Check out our Blog:

Check out our Global Market Model:

Leave a Reply

Your email address will not be published. Required fields are marked *